Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Change in Cash (2016 - 2025)

Historic Change in Cash for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $2.9 million.

  • Angiodynamics' Change in Cash rose 41397.38% to $2.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$12.5 million, marking a year-over-year decrease of 8291.46%. This contributed to the annual value of -$20.2 million for FY2025, which is 16413.98% down from last year.
  • According to the latest figures from Q4 2025, Angiodynamics' Change in Cash is $2.9 million, which was up 41397.38% from -$17.1 million recorded in Q3 2025.
  • Angiodynamics' Change in Cash's 5-year high stood at $17.6 million during Q1 2024, with a 5-year trough of -$21.1 million in Q3 2024.
  • For the 5-year period, Angiodynamics' Change in Cash averaged around -$819350.0, with its median value being -$1.0 million (2021).
  • Data for Angiodynamics' Change in Cash shows a peak YoY increase of 681141.73% (in 2024) and a maximum YoY decrease of 26235.54% (in 2024) over the last 5 years.
  • Over the past 5 years, Angiodynamics' Change in Cash (Quarter) stood at -$1.2 million in 2021, then skyrocketed by 548.18% to $5.3 million in 2022, then tumbled by 37.46% to $3.3 million in 2023, then plummeted by 127.67% to -$916000.0 in 2024, then soared by 413.97% to $2.9 million in 2025.
  • Its Change in Cash was $2.9 million in Q4 2025, compared to -$17.1 million in Q3 2025 and $11.1 million in Q2 2025.